At a glance
- Originator Yamanouchi
- Class
- Mechanism of Action Muscarinic M3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Urinary incontinence
Most Recent Events
- 07 Sep 1998 No-Development-Reported for Urinary incontinence in Japan (Unknown route)
- 29 Aug 1996 New profile
- 29 Aug 1996 Preclinical development for Urinary incontinence in Japan (Unknown route)